Lovell Stephanie 4

What Happened Stephanie Lovell, a director of TransMedics Group, Inc. (TMDX), sold 1,193 shares in an open-market transaction on March 4, 2026. The shares were disposed at $149.62 each, generating gross proceeds of approximately $178,497. This was a sale (not a purchase or option exercise), which is often a routine liquidity event rather than a direct indicator of company outlook.

Key Details

• Transaction date: 2026-03-04; sale price: $149.62 per share; shares sold: 1,193; gross value: ~$178,497.
• Transaction type/code: Open-market sale (S).
• Form 4 filed: 2026-03-06 (filed within the required reporting window; not marked late).
• Shares owned after the transaction: Not specified in the provided filing.
• Footnotes/plan references: None disclosed in the provided filing (no 10b5-1 plan or tax-withholding note reported).

Context Insider sales frequently reflect personal financial planning or portfolio rebalancing. Purchases tend to be seen as a stronger signal of insider confidence; this single, sub-$200k sale should be viewed as routine unless combined with other meaningful insider activity.